Contributors

As an assistant professor in the School of Communication at American University, Matthew Nisbet studies scientific and environmental controversies. Part of his work involves examining the interactions between experts, journalists, and the public. He tracks these issues in his blog, Framing Science (http://scienceblogs.com/framing-science). In "The Future of Public Engagement", he and Dietram Scheufele, professor of life sciences communication at the University of Wisconsin in Madison

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

As an assistant professor in the School of Communication at American University, Matthew Nisbet studies scientific and environmental controversies. Part of his work involves examining the interactions between experts, journalists, and the public. He tracks these issues in his blog, Framing Science (http://scienceblogs.com/framing-science). In "The Future of Public Engagement", he and Dietram Scheufele, professor of life sciences communication at the University of Wisconsin in Madison, write about how scientists and scientific organizations should communicate controversial issues to the media and public. "Certainly the [framing] research is very valuable" for helping scientists to engage a nonscientific audience, he says.

A correspondent for The Scientist for the last two years, Melissa Lee Phillips is a full-time freelance science writer. Her stories have appeared in Environmental Health Perspectives, BioScience, and New Scientist. Between 2001 and 2004, she worked in a neurobiology laboratory at the University of Washington in Seattle. In "Genomic Alterations 2.0", ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies